Hehui Fang

520 total citations
12 papers, 400 citations indexed

About

Hehui Fang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Hehui Fang has authored 12 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Hehui Fang's work include Lung Cancer Treatments and Mutations (5 papers), Brain Metastases and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). Hehui Fang is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Brain Metastases and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). Hehui Fang collaborates with scholars based in China and United States. Hehui Fang's co-authors include Xiaoxiang Guan, Fang Yang, Juan Jin, Zijia Sun, Wenwen Zhang, Doudou Huang, Guohua Zhou, Wenfei Ji, Yaqin Shi and Lulu Cao and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and Cell Death and Differentiation.

In The Last Decade

Hehui Fang

9 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hehui Fang China	7	229	187	186	87	36	12	400
Richard Kurupi United States	9	285 1.2×	151 0.8×	143 0.8×	114 1.3×	31 0.9×	9	432
Yaning He China	10	208 0.9×	153 0.8×	214 1.2×	82 0.9×	33 0.9×	16	423
Nadia Tosti Switzerland	10	162 0.7×	166 0.9×	135 0.7×	66 0.8×	46 1.3×	16	328
Qing-Shan Wang China	9	344 1.5×	136 0.7×	174 0.9×	51 0.6×	40 1.1×	10	462
Vera Kloten Germany	13	326 1.4×	241 1.3×	180 1.0×	73 0.8×	48 1.3×	16	502
Xiao Dong China	9	246 1.1×	162 0.9×	87 0.5×	60 0.7×	40 1.1×	12	346
Qiongyan Zou China	12	256 1.1×	255 1.4×	112 0.6×	59 0.7×	26 0.7×	35	441
Wenchen Gong China	12	203 0.9×	143 0.8×	161 0.9×	55 0.6×	58 1.6×	39	400
Valeria Pusceddu Italy	12	135 0.6×	103 0.6×	238 1.3×	72 0.8×	33 0.9×	45	382
Jung-Ah Hwang South Korea	15	279 1.2×	128 0.7×	152 0.8×	140 1.6×	24 0.7×	23	447

Countries citing papers authored by Hehui Fang

Since Specialization

Citations

This map shows the geographic impact of Hehui Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hehui Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hehui Fang more than expected).

Fields of papers citing papers by Hehui Fang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hehui Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hehui Fang. The network helps show where Hehui Fang may publish in the future.

Co-authorship network of co-authors of Hehui Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Hehui Fang. A scholar is included among the top collaborators of Hehui Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hehui Fang. Hehui Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Xie, Yuwen, et al.. (2025). Genomic profiling and prognostic factors of leptomeningeal metastasis in EGFR-mutant NSCLC after resistant to third-generation EGFR-tyrosine kinase inhibitors. Lung Cancer. 205. 108593–108593.

Fang, Hehui, Haitao Luo, Shu Xu, et al.. (2025). Serial monitoring of cerebrospinal fluid in patients with leptomeningeal metastases in lung cancer via the Ommaya reservoir as a predictive indicator of therapeutic efficacy and clinical prognosis. npj Precision Oncology. 10(1). 21–21.

Xie, Yuwen, et al.. (2025). Furmonertinib in uncommon EGFR‐mutated non‐small cell lung cancer with central nervous system metastases: A retrospective cohort study. International Journal of Cancer. 157(5). 954–963.

Xu, Ting, et al.. (2024). High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer. Journal of Neuro-Oncology. 169(1). 203–213. 1 indexed citations

Fang, Shencun, et al.. (2024). High-dose furmonertinib in combination with intraventricular chemotherapy for EGFR exon 20 insertion mutated lung adenocarcinoma with leptomeningeal metastasis.. Journal of Clinical Oncology. 42(16_suppl). e20555–e20555. 1 indexed citations

Yang, Fang, Yan Shen, Wenwen Zhang, et al.. (2018). An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer. Cell Death and Differentiation. 25(12). 2209–2220. 101 indexed citations

Jin, Juan, Hehui Fang, Fang Yang, et al.. (2018). Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer. Neoplasia. 20(5). 478–488. 74 indexed citations

Fang, Hehui, Juan Jin, Doudou Huang, Fang Yang, & Xiaoxiang Guan. (2018). PAI‐1 induces Src inhibitor resistance via CCL5 in HER2‐positive breast cancer cells. Cancer Science. 109(6). 1949–1957. 24 indexed citations

Yang, Fang, Yucai Wang, Quan Li, et al.. (2017). Intratumor heterogeneity predicts metastasis of triple-negative breast cancer. Carcinogenesis. 38(9). 900–909. 55 indexed citations

10.

Fang, Hehui, Doudou Huang, Fang Yang, & Xiaoxiang Guan. (2017). Potential biomarkers of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer. Breast Cancer Research and Treatment. 168(2). 287–297. 29 indexed citations

11.

Zhang, Wenwen, Jing Xu, Hehui Fang, et al.. (2017). Endothelial cells promote triple‐negative breast cancer cell metastasis via PAI‐1 and CCL5 signaling. The FASEB Journal. 32(1). 276–288. 77 indexed citations

12.

Yang, Fang, Lulu Cao, Zijia Sun, et al.. (2016). Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors. International Journal of Biological Sciences. 12(12). 1568–1577. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact